Lu Qiuling, Xu Mindong, Zhang Lida, Gao Li, Mao Wei, Han Wei, Xu Nenggui
Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
BMJ Open. 2024 Dec 3;14(12):e093000. doi: 10.1136/bmjopen-2024-093000.
The prevalence of obesity is rising, significantly impacting health and quality of life. Effective treatment is crucial, particularly for abdominal obesity (AO). Electroacupuncture (EA), which combines acupuncture and moxibustion with electric current, shows promise but lacks reliable clinical evidence for its efficacy and safety. Therefore, a meta-analysis is essential to assess the clinical effectiveness of EA in treating AO.
A systematic search of PubMed, Medline, Embase, the Cochrane Library, China National Knowledge Infrastructure, Wanfang and Allied and Alternative Medicine (AMED) databases will be conducted from database inception to 1 June 2024 to identify randomised controlled trials investigating the effectiveness and safety of EA in treating AO. Two authors will independently carry out data extraction and evaluate the risk of bias. RevMan software (V.5.4) will be used for data analysis, and publication bias will be assessed using funnel plots and Egger's test. The quality of evidence will be evaluated according to Grades of Recommendation, Assessment, Development, and Evaluation, and trial sequence analysis will be used to calculate the final total sample size required for the meta-analysis. The primary outcome will be the measurement of waist circumference. Secondary outcomes will include the quality of life, hip circumference, waist-to-hip ratio, body mass index, body fat percentage, visceral fat thickness and serum markers such as triglycerides, total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol. The data will be pooled and analysed, with subgroup analyses conducted if needed.
This systematic review and meta-analysis does not require ethical approval because the data for this review will be extracted from already published journal articles. The protocol for this review has been registered in the International Prospective Register of Systematic Reviews (PROSPERO). This review and its findings will be published in a peer-reviewed journal or presented at scientific conferences.
CRD42024562984.
肥胖症的患病率正在上升,对健康和生活质量产生重大影响。有效的治疗至关重要,尤其是对腹型肥胖(AO)而言。电针(EA)将针刺和艾灸与电流相结合,显示出一定前景,但缺乏关于其疗效和安全性的可靠临床证据。因此,进行一项荟萃分析对于评估电针治疗腹型肥胖的临床有效性至关重要。
将从数据库建立至2024年6月1日对PubMed、Medline、Embase、Cochrane图书馆、中国知网、万方以及联合与替代医学(AMED)数据库进行系统检索,以识别研究电针治疗腹型肥胖有效性和安全性的随机对照试验。两名作者将独立进行数据提取并评估偏倚风险。将使用RevMan软件(V.5.4)进行数据分析,并使用漏斗图和Egger检验评估发表偏倚。将根据推荐分级、评估、制定与评价(GRADE)来评估证据质量,并使用试验序贯分析来计算荟萃分析所需的最终总样本量。主要结局将是腰围测量。次要结局将包括生活质量、臀围、腰臀比、体重指数、体脂百分比、内脏脂肪厚度以及甘油三酯、总胆固醇、低密度脂蛋白和高密度脂蛋白胆固醇等血清标志物。将汇总并分析数据,必要时进行亚组分析。
本系统评价和荟萃分析无需伦理批准,因为本评价的数据将从已发表的期刊文章中提取。本评价方案已在国际系统评价前瞻性注册库(PROSPERO)中注册。本评价及其结果将发表在同行评审期刊上或在科学会议上展示。
PROSPERO注册号:CRD42024562984。